{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T06:10:12Z","timestamp":1733465412966,"version":"3.30.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T00:00:00Z","timestamp":1726617600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.imlet.2024.106929","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T16:03:29Z","timestamp":1726761809000},"page":"106929","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Reassuring humoral and cellular immune responses to SARS-CoV-2 vaccination in participants with systemic sclerosis"],"prefix":"10.1016","volume":"270","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8767-933X","authenticated-orcid":false,"given":"Jenna M.","family":"Benoit","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5434-9158","authenticated-orcid":false,"given":"Jessica A.","family":"Breznik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3710-8854","authenticated-orcid":false,"given":"Angela","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5313-5724","authenticated-orcid":false,"given":"Braeden","family":"Cowbrough","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4633-4346","authenticated-orcid":false,"given":"Lauren","family":"Heessels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1585-8042","authenticated-orcid":false,"given":"Sumiya","family":"Lodhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1706-3158","authenticated-orcid":false,"given":"Elizabeth","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hina","family":"Bhakta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rumi","family":"Clare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5695-4343","authenticated-orcid":false,"given":"Ishac","family":"Nazy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2874-6886","authenticated-orcid":false,"given":"Jonathan L.","family":"Bramson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maggie J.","family":"Larch\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawn ME","family":"Bowdish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2024.106929_bib0001","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.imlet.2017.10.002","article-title":"Current perspectives on the role of CD8+ T cells in systemic sclerosis","volume":"195","author":"Fuschiotti","year":"2018","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.imlet.2024.106929_bib0002","doi-asserted-by":"crossref","first-page":"e566","DOI":"10.1016\/S2665-9913(22)00130-8","article-title":"Systemic sclerosis in the time of COVID-19","volume":"4","author":"Hoffmann-Vold","year":"2022","journal-title":"Lancet Rheumatol."},{"key":"10.1016\/j.imlet.2024.106929_bib0003","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/s41584-019-0184-z","article-title":"Emerging targets of disease-modifying therapy for systemic sclerosis","volume":"15","author":"Volkmann","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.imlet.2024.106929_bib0004","doi-asserted-by":"crossref","first-page":"5947","DOI":"10.1038\/s41467-021-26099-w","article-title":"Interleukin-31 promotes fibrosis and T helper 2 polarization in systemic sclerosis","volume":"12","author":"Kuzumi","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.imlet.2024.106929_bib0005","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.1093\/rheumatology\/keab168","article-title":"IL11 is elevated in systemic sclerosis and IL11-dependent ERK signalling underlies TGF\u03b2-mediated activation of dermal fibroblasts","volume":"60","author":"Adami","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.imlet.2024.106929_bib0006","article-title":"Intensity of mycophenolate mofetil treatment is associated with an impaired immune response to SARS-CoV-2 vaccination in kidney transplant recipients","author":"Kantauskaite","year":"2021","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.imlet.2024.106929_bib0007","doi-asserted-by":"crossref","first-page":"e627","DOI":"10.1016\/S2665-9913(21)00212-5","article-title":"The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study","volume":"3","author":"Mahil","year":"2021","journal-title":"Lancet Rheumatol."},{"key":"10.1016\/j.imlet.2024.106929_bib0008","doi-asserted-by":"crossref","unstructured":"R.M. Dayam, J.C. Law, R.L. Goetgebue, G.Y.C. Chao, K.T. Abe, M. Sutton, N. Finkelstein, J.M. Stempak, D. Pereirau, D. Croitor, et al., Accelerated waning of immunity to SARS-CoV-2 mRNA vaccines in patients with immune-mediated inflammatory diseases, JCI Insight 7 (2022) e159721, 10.1172\/jci.insight.159721.","DOI":"10.1172\/jci.insight.159721"},{"key":"10.1016\/j.imlet.2024.106929_bib0009","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1093\/rheumatology\/keab223","article-title":"COVID-19 vaccination and antirheumatic therapy","volume":"60","author":"Arnold","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.imlet.2024.106929_bib0010","doi-asserted-by":"crossref","first-page":"SI169","DOI":"10.1093\/rheumatology\/keab886","article-title":"SARS-CoV-2 vaccine in patients with systemic sclerosis: impact of disease subtype and therapy","volume":"61","author":"Sampaio-Barros","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.imlet.2024.106929_bib0011","doi-asserted-by":"crossref","first-page":"eabq7647","DOI":"10.1126\/sciimmunol.abq7647","article-title":"CD8 T Cells Contribute to Vaccine Protection Against SARS-CoV-2 in Macaques","volume":"0","author":"Liu","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.imlet.2024.106929_bib0012","doi-asserted-by":"crossref","first-page":"e348","DOI":"10.1016\/S2666-5247(22)00036-2","article-title":"SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in people recovered from COVID-19: a longitudinal cohort study","volume":"3","author":"Guo","year":"2022","journal-title":"Lancet Microbe."},{"key":"10.1016\/j.imlet.2024.106929_bib0013","first-page":"1","article-title":"SARS-CoV-2-specific T cell therapy for severe COVID-19: a randomized phase 1\/2 trial","author":"Papadopoulou","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.imlet.2024.106929_bib0014","doi-asserted-by":"crossref","first-page":"5422","DOI":"10.1038\/s41467-022-32985-8","article-title":"Magnitude of venous or capillary blood-derived SARS-CoV-2-specific T cell response determines COVID-19 immunity","volume":"13","author":"Scurr","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.imlet.2024.106929_bib0015","doi-asserted-by":"crossref","first-page":"R147","DOI":"10.1186\/ar2821","article-title":"Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations","volume":"11","author":"Gourh","year":"2009","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.imlet.2024.106929_bib0016","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.biopha.2018.09.037","article-title":"Imbalance between T helper 17 and regulatory T cell subsets plays a significant role in the pathogenesis of systemic sclerosis","volume":"108","author":"Mo","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.imlet.2024.106929_bib0017","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/mi.2009.100","article-title":"Th17 cells at the crossroads of innate and adaptive immunity against infectious diseases at the mucosa","volume":"2","author":"Khader","year":"2009","journal-title":"Mucosal. Immunol."},{"key":"10.1016\/j.imlet.2024.106929_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102494","article-title":"Gender-related differences in systemic sclerosis","volume":"19","author":"Hughes","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.imlet.2024.106929_bib0019","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1073\/pnas.1321060111","article-title":"Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination","volume":"111","author":"Furman","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.imlet.2024.106929_bib0020","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/ije\/23.5.1078","article-title":"Sex differences in the humoral antibody response to live measles vaccine in young adults","volume":"23","author":"Green","year":"1994","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.imlet.2024.106929_bib0021","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1007\/s10067-022-06219-7","article-title":"Antibody response to BNT162b2 SARS-CoV-2 mRNA vaccine in adult patients with systemic sclerosis","volume":"41","author":"Pellicano","year":"2022","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.imlet.2024.106929_bib0022","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.3389\/fimmu.2018.02356","article-title":"Regulatory T cells in systemic sclerosis","volume":"9","author":"Frantz","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imlet.2024.106929_bib0023","article-title":"The dynamic role of FOXP3+ tregs and their potential therapeutic applications during SARS-CoV-2 infection","volume":"13","author":"Xu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imlet.2024.106929_bib0024","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.2200369","article-title":"Cytomegalovirus seropositivity in older adults changes the T cell repertoire but does not prevent antibody or cellular responses to SARS-CoV-2 vaccination","author":"Breznik","year":"2022","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2024.106929_bib0025","doi-asserted-by":"crossref","first-page":"22846","DOI":"10.1038\/s41598-023-50263-5","article-title":"Immunomodulatory drugs have divergent effects on humoral and cellular immune responses to SARS-CoV-2 vaccination in people living with rheumatoid arthritis","volume":"13","author":"Benoit","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.imlet.2024.106929_bib0026","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3390\/v13040697","article-title":"Characteristics of Anti-SARS-CoV-2 Antibodies in Recovered COVID-19 Subjects","volume":"13","author":"Huynh","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.imlet.2024.106929_bib0027","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0281673","article-title":"Comparison of three dosing intervals for the primary vaccination of the SARS-CoV-2 mRNA Vaccine (BNT162b2) on magnitude, neutralization capacity and durability of the humoral immune response in health care workers: a prospective cohort study","volume":"18","author":"Leong","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.imlet.2024.106929_bib0028","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.3390\/v13112239","article-title":"Lasting Changes to Circulating Leukocytes in People with Mild SARS-CoV-2 Infections","volume":"13","author":"Kennedy","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.imlet.2024.106929_bib0029","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1002\/eji.201344102","article-title":"Human antigen-specific CD4+CD25+CD134+CD39+ T cells are enriched for regulatory T cells and comprise a substantial proportion of recall responses","volume":"44","author":"Seddiki","year":"2014","journal-title":"Eur. J. Immunol."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247824001032?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247824001032?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T05:47:11Z","timestamp":1733464031000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247824001032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":29,"alternative-id":["S0165247824001032"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2024.106929","relation":{},"ISSN":["0165-2478"],"issn-type":[{"type":"print","value":"0165-2478"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reassuring humoral and cellular immune responses to SARS-CoV-2 vaccination in participants with systemic sclerosis","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2024.106929","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V. on behalf of European Federation of Immunological Societies.","name":"copyright","label":"Copyright"}],"article-number":"106929"}}